Spandana Sphoorty Financial Fund Raise

Earnings Call

Spandana Sphoorty Financial Earnings Call Transcript: Key Takeaways

Spandana shows operational recovery with AUM crossing ₹5,000 Cr, but masks stress via ARC sales.

Other Announcement

Spandana Sphoorty Financial Other Announcement

CARE's quarterly monitoring report found no deviation in Spandana's rights issue proceeds. No proceeds were utilised during the quarter, with funds held in escrow.

Execution

Issue period August 01, 2025 to March 31, 2027

Earnings Call

Spandana Sphoorty Financial Investor Presentation: Key Takeaways

Q2 FY27 PAT ₹18 Cr (PBT ₹37 Cr) on AUM ₹5,364 Cr (+10% QoQ). NIM rose to 13.6%, GNPA fell to 2.54%, and the turnaround continued.

Results Update

Spandana Sphoorty Financial Results Update

Spandana Sphoorty reported Q2 FY27 PAT of Rs.18 Crore and PPOP of Rs.79 Crore in its press release. AUM rose 10% QoQ to Rs.5,364 Crore.

Financial ResultsAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Spandana Sphoorty Financial Q2 FY27 Results: Turns Profitable, Net Profit ₹18.2 Cr

Spandana Sphoorty Financial Ltd reported revenue from operations of ₹324.9 Cr (+41.5% YoY) and net profit of ₹18.2 Cr for Q2 FY27.

Key figure

Net profit ₹18.2 Cr

Debt & Borrowing

Spandana Sphoorty Financial Debt & Borrowing: ₹0.49 Cr

Spandana paid ₹0.49 Crore of quarterly interest on its secured NCDs on 27 October 2026. The coupon rate is 10.75% on a ₹50 Crore issue.

Value

₹0.49 Cr

Fund RaiseSudarshan Pharma Industries Ltd SUDARSHANAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Fund RaiseFlywings Simulator Training Centre Ltd FWSTCAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Fund RaiseKanel Industries Ltd KANELOILAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Fund RaiseSudarshan Pharma Industries Ltd SUDARSHANAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

Fund RaiseGAIL (India) Ltd GAILAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.

Fund RaiseGujarat Inject (Kerala) Ltd 524238Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Gujarat Inject (Kerala) Fund Raise of ₹3 Cr

Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.

Value

₹3.00 Cr